Alternative and complementary therapies for vulvovaginal candidiasis

@article{Felix2018AlternativeAC,
  title={Alternative and complementary therapies for vulvovaginal candidiasis},
  author={T. Felix and Denise Von Dolinger de Brito R{\"o}der and Reginaldo dos Santos Pedroso},
  journal={Folia Microbiologica},
  year={2018},
  volume={64},
  pages={133-141}
}
When it comes to women’s health, treating vaginal infections makes up a high proportion of the gynecological services. Among the forms of vaginitis, vulvovaginal candidiasis (VVC) is considered the second most common. Demand for new treatment alternatives is increasingly relevant, especially for therapies with fewer side effects, better tolerability, and lower cost, while still offering improved quality of life in terms of disease prevention. This study intended to investigate the alternative… Expand

Paper Mentions

Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options
Purpose of Review Vulvovaginal candidiasis (VVC) is an infection of the vaginal mucosa caused by fungi of the genus Candida and can become pathogenic under special conditions. It affects about 75% ofExpand
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)
Approximately 70‐75% of women will have vulvovaginal candidosis (VVC) at least once in their lifetime. In premenopausal, pregnant, asymptomatic and healthy women and women with acute VVC, CandidaExpand
Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients
TLDR
Molecular analyses should be used to improve diagnosis and give appropriate treatment of vulvovaginitis caused by non-albicans Candida, which are becoming very important due to their high levels of antifungal resistance. Expand
Effects of Acetic Acid Vaginal Gel on Vulvovaginal Candidiasis: A Double Blind Randomized Controlled Trial
TLDR
The study showed that acetic acid vaginal gel could have a significant effect on the definitive cure of VVC. Expand
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
TLDR
This narrative review covers the existing state of understanding of the epidemiology, pathogenesis and diagnosis of Vulvovaginal candidosis, and recommends treatment recommendations should follow current guidelines. Expand
Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: a randomized clinical trial.
TLDR
A clinical trial was designed to assess the efficacy of a novel herbal suppository, containing myrtle and oak gall (MOGS) in treatment of vaginitis and found MOGS would be a chance for developing new treatment for trichomoniasis. Expand
Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).
TLDR
This guideline gives recommendations for the diagnosis, management, counseling, prophylaxis and screening of vulvovaginal candidosis. Expand
Candida albicans vaginitis in a murine model is reduced by polypeptide-enriched Gastrodia elata extracts.
TLDR
Results showed the potential application of GE as an antifungal agent in VVC treatment and had an inhibitory effect on the proliferation of C. albicans and inflammatory reaction. Expand
Evaluation of the vaginal microbiome in clinical diagnosis and management of vaginal infectious diseases
TLDR
The establishment of VMES has a high clinical value in the treatment of vaginal infections and opens up new opportunities for the comprehensive management of dysbacteriosis when such infections occur. Expand
Antifungal susceptibility and virulence profile of candida isolates from abnormal vaginal discharge of women from southern India.
TLDR
This study clarified the antifungal susceptibility and virulence behaviour of Candida isolates; this will be of use in the selection of antIfungal agents for Candida prophylaxis. Expand
...
1
2
...

References

SHOWING 1-10 OF 91 REFERENCES
Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
TLDR
Despite the promising results of some studies, further research is needed to prove the effectiveness of probiotics in preventing the recurrences of VVC and to allow their wide use for this indication. Expand
Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
TLDR
The findings suggest that boric acid is a safe, alternative, economic option for women with recurrent and chronic symptoms of vaginitis when conventional treatment fails because of the involvement of non-albicans Candida spp. Expand
Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis
TLDR
The vaginal cream containing garlic and thyme is effective as much as clotrimazole vaginal cream for the treatment of candida vaginitis and there is no difference between responses to treatment by these two drugs. Expand
Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis.
TLDR
Garcin tablets could be a suitable alternative to fluconazole for the treatment of Candida vaginitis, according to the results of the present study. Expand
Alternative Therapies in Women With Chronic Vaginitis
TLDR
Complementary alternative medicine use is common in women with chronic vaginitis, particularly in those who are young, have more disruptive symptoms, and report greater stress. Expand
Does vaginal douching affect the type of candidal vulvovaginal infection?
TLDR
It was found that vaginal douching does not influence the type of Candida infection involved in VVC, and frequent performance of VD increases the likelihood of having non-albicans types and the resistance to the common antifungal agents. Expand
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
TLDR
Topical boric acid and flucytosine are useful additions to therapy for women with azole-refractory C glabrata vaginitis. Expand
Clinical, microbiological and therapeutic aspects of vulvovaginal candidiasis and recurrent vulvovaginal candidiasis: importance of regional surveys
TLDR
The epidemiological relevance of etiological diagnosis and antifungigram in clinical treatment is discussed and increased resistance to azoles and poliens, the drugs of choice for treatment, is presented. Expand
Candidiasis vulvovaginal: una antigua enfermedad con nuevos desafíos
TLDR
The most significant developments related to the fungal virulence factors, the role of the immunological mechanisms involved in the vaginal protection, and the genetic alterations that confer susceptibility to the recurrent form of this mycosis are presented. Expand
Comprehensive review of conventional and non‐conventional methods of management of recurrent vulvovaginal candidiasis
Recurrent vulvovaginal candidiasis (VVC) is a condition what causes women a great deal of discomfort, inconvenience, and sometimes has psychological sequelae. 1 This condition is notoriouslyExpand
...
1
2
3
4
5
...